Component: (Network and Table)
Network
00100 - Statement - CONSOLIDATED BALANCE SHEETS
(http://www.americanrenal.com/role/StatementConsolidatedBalanceSheets)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001498068 (http://www.sec.gov/CIK)
CONSOLIDATED BALANCE SHEETSPeriod [Axis]
2016-12-31
2015-12-31
CONSOLIDATED BALANCE SHEETS
 
 
Assets
 
 
Current assets
 
 
Cash
100,916,000  
90,988,000  
Accounts receivable, less allowance for doubtful accounts of $8,726 and $7,435 at December 31, 2016 and 2015, respectively
81,127,000  
76,919,000  
Inventories
4,676,000  
4,291,000  
Prepaid expenses and other current assets
18,498,000  
18,863,000  
Income tax receivable
5,163,000  
2,686,000  
Total current assets
210,380,000  
 
193,747,000  
 
Property and equipment, net
170,118,000  
142,701,000  
Intangible assets, net
25,626,000  
25,662,000  
Other long-term assets
6,753,000  
6,850,000  
Goodwill
573,147,000  
569,318,000  
Total assets
986,024,000  
 
938,278,000  
 
Liabilities and Equity
 
 
Current liabilities:
 
 
Accounts payable
31,127,000  
22,571,000  
Accrued compensation and benefits
29,103,000  
22,504,000  
Accrued expenses and other current liabilities
45,286,000  
26,788,000  
Current portion of long-term debt
48,274,000  
25,610,000  
Total current liabilities
153,790,000  
 
97,473,000  
 
Long-term debt, less current portion
522,058,000  
657,372,000  
Income tax receivable agreement payable
21,200,000  
 
Other long-term liabilities
11,670,000  
9,483,000  
Deferred tax liabilities
1,278,000  
15,029,000  
Total Liabilities
709,996,000  
 
779,357,000  
 
Commitments and contingencies (Notes 19 and 20)
xsi:nil  
xsi:nil  
Noncontrolling interests subject to put provisions
130,365,000  
108,211,000  
Equity:
 
 
Preferred stock, $0.01 par value, 1,000,000 shares authorized; none issued
xsi:nil  
xsi:nil  
Common stock, $0.01 par value, 300,000,000 and 29,770,000 shares authorized, 30,894,962 and 22,213,967 issued and outstanding at December 31, 2016 and 2015, respectively
184,000  
98,000  
Additional paid-in capital
95,062,000  
 
Receivable from noncontrolling interests
(544,000) 
(529,000) 
Accumulated deficit
(128,646,000) 
(128,261,000) 
Accumulated other comprehensive (loss) income, net of tax
(100,000) 
(501,000) 
Total American Renal Associates Holdings, Inc. deficit
(34,044,000) 
 
(129,193,000) 
 
Noncontrolling interests not subject to put provisions
179,707,000  
179,903,000  
Total equity
145,663,000  
 
50,710,000  
 
Total liabilities and equity
986,024,000  
 
938,278,000